Plain-English translation of NCT07290751 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
When someone has a stroke caused by a blood clot, doctors give an urgent clot-busting medication called thrombolysis. But some patients don't improve as much as doctors hope within the first hour. This trial tests whether adding , a medication that prevents platelets (blood clot-forming cells) from sticking together, can help these patients recover better.
Many stroke patients still have lasting disability even after receiving standard clot-busting treatment. Doctors think adding an extra anti-clotting medication like early on might prevent new clots from forming and improve recovery, but we need solid evidence that this treatment is both safe and effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to receive either the new medication () or a placebo (salt water) through an IV for 24 hours while you're in the hospital. Both groups then switch to standard oral blood-thinning pills. You'll have brain imaging and neurological exams at specific timepoints, and return for follow-up visits at 1 month and 3 months to check your recovery and overall quality of life.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China